NANOVIRICIDES, INC. Increase (Decrease) in Prepaid Expenses, Other
NANOVIRICIDES, INC. (NNVC) reported Increase (Decrease) in Prepaid Expenses, Other of $370.19 thousand for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2017-05-15
- NANOVIRICIDES, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2014-09-30 was -$284.82K.
- NANOVIRICIDES, INC. increase (decrease) in prepaid expenses, other for fiscal 2015 was -$266.74K, a 333.31% decline from fiscal 2014.
- NANOVIRICIDES, INC. increase (decrease) in prepaid expenses, other for fiscal 2014 was $114.33K.
- NANOVIRICIDES, INC. increase (decrease) in prepaid expenses, other for fiscal 2013 was -$344.89K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed |
|---|---|---|---|---|
| 2017-03-31 | $370.19K 10-Q · filed 2017-05-15 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | |||
| 2015-06-30 | -$266.74K 10-K · filed 2015-09-14 | |||
| 2014-09-30 | -$284.82K 10-Q/A · filed 2015-02-23 | |||
| 2014-06-30 | $114.33K 10-K · filed 2015-09-14 | $162.44K 10-K · filed 2015-02-23 | ||
| 2013-06-30 | -$344.89K 10-K · filed 2015-09-14 | $0.00 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |